South Korea’s proportion of hard-core vegetarians has turned out to be a minimal 7.6 percent, with 92.4 percent being non-vegetarians, according to a survey by the Korea Agro-Fisheries & Food Trade Corp. on 5,510 adult respondents.
The survey was delegated by local pollster Global Research based on seven levels of vegetarian practice.
The ‘flexitarians,' or vegetarians who eat meat on occasion, made up 79.7 percent of the population or 333 persons.
The ‘pollos' who eat milk, eggs, fish, and chicken but not beef or pork made up 11% of the population, whereas the 'pescos,' who only consume seafood, comprised 6.2 percent.
In total, flexitarians, pollos, and pescanos accounted for 96.9 percent of the population.
Only 3.1 percent of vegetarians ate no meat of any kind. That's 0.2 percent of all respondents in the poll.
Only 0.7 percent of the group were classified as ‘lacto-ovos,' those who eat only eggs and milk, while 1.4 percent comprised the ‘ovos,' or egg eaters, who do not consume milk.
Of the respondents, 0.5 percent were made up of persons labeled with the term ‘lactos,' who eat fruits, vegetables, and milk, and another 0.5 percent were vegans,' who only consume vegetables and fruits.


Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
The four types of dementia most people don’t know exist
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
ECB Eyes Rate Hike Amid Iran Conflict-Driven Energy Price Surge
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions
Asian Currencies Hold Steady as Dollar Stays Firm Amid Middle East Uncertainty 



